Literature DB >> 15469033

Bootstrap investigation of the stability of disease mapping of Bayesian cancer relative risk estimations.

Marc Colonna1.   

Abstract

BACKGROUND: Bayesian approaches to disease mapping of relative risks are useful for rare disease when geographical units have very different population sizes. As Bayesian approaches may induce very different estimations, it is useful to consider the stability of the estimations as a criterion for evaluating the quality of the results. MATERIAL: Cancer incidence data, from the Isere cancer registry (France) over the 1985-1994 period, have been used to check the proposed method: the study is based on 22 cancer sites among males and 24 among females.
METHOD: A bootstrap approach has been retained to evaluate the stability of the estimations. The coefficient of variation was chosen as an indicator of stability. Three Bayesian models corresponding to global, local and combined smoothing techniques, have been considered. The stability analysis has taken account of the results of spatial autocorrelation and heterogeneity tests.
RESULTS: Bayesian approaches do not necessarily lead to stable estimations. The local smoothing approach induces estimations that are often unstable. The global smoothing approach is the most stable, but is conservative. Combined smoothing appears to be a good compromise if significant spatial variations and heterogeneity of relative risks exist.
CONCLUSION: Bayesian estimations of relative risks may be very unstable. However, when results of spatial autocorrelation and heterogeneity tests are taken into account to choose between the different Bayesian approaches, instability becomes negligible.

Entities:  

Mesh:

Year:  2004        PMID: 15469033     DOI: 10.1023/b:ejep.0000036570.33081.fa

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  [Quality specifications and allowable standards for validation of methods used in clinical biochemistry].

Authors:  A Vassault; D Grafmeyer; J de Graeve; R Cohen; A Beaudonnet; J Bienvenu
Journal:  Ann Biol Clin (Paris)       Date:  1999 Nov-Dec       Impact factor: 0.459

2.  Editorial comment on Geographical differences in cancer incidence in the Belgian Province of Limburg by Bruntinx and colleagues.

Authors:  L Jarup; N Best
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

3.  Geographical epidemiology of prostate cancer in Great Britain.

Authors:  Lars Jarup; Nicky Best; Mireille B Toledano; Jon Wakefield; Paul Elliott
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

4.  Late detection of breast and colorectal cancer in Minnesota counties: an application of spatial smoothing and clustering.

Authors:  AvisJ Thomas; Bradley P Carlin
Journal:  Stat Med       Date:  2003-01-15       Impact factor: 2.373

5.  [Empirical Bayes estimates of relative risk: principles and examples].

Authors:  M Colonna
Journal:  Rev Epidemiol Sante Publique       Date:  1997-04       Impact factor: 1.019

6.  Empirical Bayes estimates of age-standardized relative risks for use in disease mapping.

Authors:  D Clayton; J Kaldor
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

7.  [Detecting spatial autocorrelation of cancer risk when population density is heterogeneous].

Authors:  M Colonna; J Estève; F Ménégoz
Journal:  Rev Epidemiol Sante Publique       Date:  1993       Impact factor: 1.019

8.  Bootstrap investigation of the stability of a Cox regression model.

Authors:  D G Altman; P K Andersen
Journal:  Stat Med       Date:  1989-07       Impact factor: 2.373

9.  Geographical differences in cancer incidence in the Belgian province of Limburg.

Authors:  F Buntinx; H Geys; D Lousbergh; G Broeders; E Cloes; D Dhollander; L Op De Beeck; J Vanden Brande; A Van Waes; G Molenberghs
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  Population mixing and leukaemia in young people around the La Hague nuclear waste reprocessing plant.

Authors:  O Boutou; A-V Guizard; R Slama; D Pottier; A Spira
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.